- Home
- A-Z Publications
- Current Drug Metabolism
- Previous Issues
- Volume 22, Issue 12, 2021
Current Drug Metabolism - Volume 22, Issue 12, 2021
Volume 22, Issue 12, 2021
-
-
Medicinal Plants and Natural Products: More Effective and Safer Pharmacological Treatment for the Management of Obesity
Authors: Harsha Negi, Meenakshi Gupta, Ramanpreet Walia, Moayad Khataibeh and Maryam SarwatObesity is a major lifestyle disorder, and it is correlated with several ailments. The prevalence of obesity has elevated over the years, and it has become a global health problem. The drugs presently used for managing obesity have several side effects, such as diarrhea, leakage of oily stools, etc. On the contrary, herbal plants and natural products are considered safe for use because they have lesser side effects. New compou Read More
-
-
-
New Horizons in the Treatment of Neurological Disorders with Tailorable Gold Nanoparticles
Authors: Farheen, Md. A. Khan, Ghulam Md. Ashraf, Anwar L. Bilgrami and M. Moshahid A. RizviNeurological disorders, such as epilepsy, dementia, Parkinson’s disease and Alzheimer’s disease, occur due to disorganization of the neurons in the nervous system. Disturbances in the nervous system cause problems with the memory, senses and moods. In order to treat such disorders, scientists have been working extensively, utilizing different approaches. Nanoneurotechnology has emerged as a promising tool to mana Read More
-
-
-
Theoretical Formulation Strategies towards Neutralizing Inter-individual Variability Associated with Tacrolimus Immunosuppressant Therapy: A Case Study on Nextgeneration Personalized Medicine
Authors: Arun Radhakrishnan and Gowthamarajan KuppusamyIndividualizing drug therapy and attaining maximum benefits of a drug devoid of adverse reactions is the benefit of personalized medicine. One of the important factors contributing to inter-individual variability is genetic polymorphism. As of now, dose titration is the only followed golden standard for implementing personalized medicine. Converting the genotypic data into an optimized dose has become easier now due to Read More
-
-
-
Effect of Carbonized Herba schizonepetae on the Bioavailability of Eight Active Components from Pulsatillae Decoction in its Particular Adsorption and Release Performance
Authors: Cuiyan Liu, Yun Zhu, Yanfei He, Guangtai Fan, Jingang Gu and Chunyang HanBackground: Carbonized herbal medicine has been used clinically for centuries in China; however, its influence on the bioavailability of compatible medicinal herbs is still unknown. Objectives: To explore the effect of a carbonized herbal medicine on the in vivo adsorption and release and absorption of other active pharmaceutical ingredients in a compound prescription. Methods: The bioavailability of carbonized Herba schi Read More
-
-
-
Clopidogrel-herb Interactions: A Pharmacokinetic and Pharmacodynamic Assessment in a Rat Model
Authors: Khalid Alkharfy, Basit Jan, Khalid Alotaibi, Ayedh Alotaibi, Saeed Alqahtani, Mohammad Raish and Ajaz AhmadBackground: Herbs usually contain a mixture of biologically active constituents, which can interact with numerous prescribed drugs and alter their safety profiles. Objectives: The current investigation was aimed to evaluate the effect of commonly used herbal products including black seed (Nigella sativa), garden cress (Lepidium sativum), and fenugreek (Trigonella foenum-graecum) on the pharmacokinetics and pharmacod Read More
-
-
-
Thymoquinone Lipid Nanoparticles Cut the Gordian Knots of Depression via Neuroprotective BDNF and Downregulation of Neuro-inflammatory NF-ΚB, IL-6, and TNF-α in LPS Treated Rats
Authors: Mahtab Alam, Md. N. Javed, Abul Kalam Najmi, Farhan Jalees Ahmad, Syed Sarim Imam and Mohd AkhtarBackground: In over 300 million clinical cases, antidepressant drugs seem to provide only symptomatic relief and limited protection in life-threatening depressive events. Objectives: To compare neuronal-signaling mechanism and neuroprotective roles of Thymoquinone (TQ) suspension and its SLN (TQSLN) against standard antidepressant drug fluoxetine. Methods: This research investigated in-silico docking at NF-KB p50 Read More
-
-
-
Influence of CYP2C9 Polymorphisms on Plasma Concentration of Warfarin and 7-Hydroxy Warfarin in South Indian Patients
Background: Warfarin is primarily metabolized by cytochrome P450 2C9 (CYP2C9) enzyme, which is encoded by the CYP2C9 gene. CYP2C9*2 and CYP2C9*3 variants significantly influence warfarin metabolism and subsequently the required dose of warfarin. Objectives: The current retrospective study was aimed to determine the influence of CYP2C9 variants on warfarin metabolic ratio (MR, warfarin/7-hydroxy warfa Read More
-
-
-
Corrigendum to: Chloro-s-triazenes-toxicokinetic, Toxicodynamic, Human Exposure, and Regulatory Considerations
Authors: Khaled Abass, Olavi Pelkonen and Arja RautioAn error appeared in the graphical abstract and figure no. 1 of the article entitled “Chloro-s-triazines-toxicokinetic, toxicodynamic, human exposure, and regulatory considerations” by Khaled Abass, Olavi Pelkonen and Arja Rautio, Current Drug Metabolism 2021, 22(8), 645-656. We regret the error and apologize to readers. The original article can be found online at https://doi.org/10.2174/1389200222666210701164945
-
Volumes & issues
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cdm
Journal
10
5
false
en
